JERICA WILLS: Open Payments
NPI 1477009421 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$728 in 41 payments from 15 companies in 2025. Trend: 2023 $1,019 · 2024 $408 · 2025 $728
Food & beverage: $696Education: $32
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $145 |
| Novo Nordisk Inc | 5 | $96 |
| Novartis Pharmaceuticals Corporation | 3 | $62 |
| Janssen Biotech, Inc. | 3 | $58 |
| Lilly USA, LLC | 3 | $58 |
| Amgen Inc. | 2 | $49 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Paratek Pharmaceuticals, Inc. | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Corcept Therapeutics | 2 | $34 |
Products named: RINVOQ, COSENTYX, TREMFYA, SKYRIZI, NUZYRA, MOUNJARO, Korlym, XIFAXAN.
Industry payments across FL — which companies pay providers there.
